Plasma bilirubin level and oxidative stress in preterm infants

C Dani, E Martelli, G Bertini, M Pezzati, L Filippi, M Rossetti, G Rizzuti, F F Rubaltelli, C Dani, E Martelli, G Bertini, M Pezzati, L Filippi, M Rossetti, G Rizzuti, F F Rubaltelli

Abstract

Objective: To assess the hypothesis that changes in plasma total bilirubin levels (Btot) can influence the antioxidant system and oxidative stress in preterm infants.

Methods: Twenty two healthy preterm infants who presented with visible non-haemolytic hyperbilirubinaemia were studied at the mean (SD) age of 3.7 (1.5) days. Btot, plasma total hydroperoxide concentration (TH), plasma protein SH group concentration, and total antioxidant capacity of the plasma (TAC) were measured at study entry and after 24 hours.

Results: Btot did not correlate with TH, TAC, or protein SH group concentration, but a significant correlation was found between TH and TAC, TH and protein SH groups, and TAC and protein SH groups, both at study entry and after 24 hours.

Conclusion: The decrease in plasma bilirubin was contemporary with an increase in plasma antioxidant capacity and decrease in oxidative stress in preterm infants. This may be the result of the pro-oxidant effect of haem oxygenase, mediated by iron release, which may outcompete the antioxidant properties of bilirubin.

Figures

Figure 1
Figure 1
Correlation between plasma total hydroperoxide concentration (TH) and total antioxidant capacity of the plasma (TAC) at study entry (A) and after 24 hours (B).
Figure 2
Figure 2
Correlation between plasma levels of protein SH groups (SH) and total hydroperoxides (TH) at study entry (A) and after 24 hours (B).
Figure 3
Figure 3
Correlation between plasma levels of protein SH groups (SH) and total antioxidant capacity of the plasma (TAC) at study entry (A) and after 24 hours (B).

References

    1. Biochem Soc Trans. 1982 Apr;10(2):72-3
    1. Curr Top Cell Regul. 2000;36:181-99
    1. Biochem J. 1999 Nov 15;344 Pt 1:153-8
    1. Clin Chem. 1998 Dec;44(12):2551-3
    1. Cancer Res. 1991 Feb 1;51(3):974-8
    1. Biol Neonate. 1991;60(5):320-6
    1. J Biol Chem. 1997 Jun 6;272(23):14937-42
    1. Proc Natl Acad Sci U S A. 1987 Nov;84(22):8130-4
    1. Am J Physiol. 1999 Mar;276(3 Pt 1):L443-51
    1. Am J Respir Cell Mol Biol. 1996 Jun;14(6):556-68
    1. Clin Sci (Lond). 1993 Apr;84(4):407-12
    1. J Clin Invest. 1998 Mar 1;101(5):1001-11
    1. Proc Assoc Am Physicians. 1999 Sep-Oct;111(5):438-47
    1. Proc Natl Acad Sci U S A. 1987 Aug;84(16):5918-22
    1. FEBS Lett. 1994 Aug 1;349(2):197-200
    1. Arch Biochem Biophys. 1959 May;82(1):70-7
    1. Pediatr Res. 1999 Mar;45(3):355-62
    1. Pediatrics. 2001 Jun;107(6):1264-71
    1. Proc Natl Acad Sci U S A. 1994 Mar 29;91(7):2607-10
    1. Mol Cell Biol. 1990 Sep;10(9):4967-9
    1. J Biol Chem. 1992 Sep 5;267(25):18148-53
    1. Biochem Cell Biol. 1991 Oct-Nov;69(10-11):683-8
    1. Arch Dis Child Fetal Neonatal Ed. 1999 May;80(3):F235-7
    1. Carcinogenesis. 1992 Feb;13(2):227-32
    1. Free Radic Biol Med. 1995 Oct;19(4):395-404
    1. Am J Perinatol. 2000;17(4):167-81
    1. Pediatr Res. 2000 Feb;47(2):221-4
    1. Biol Neonate. 1997;71(4):233-8
    1. Science. 1987 Feb 27;235(4792):1043-6
    1. Haematologica. 2001 Jan;86(1):85-91

Source: PubMed

Szponzorok és közreműködők

Egészségi állapot

Kábítószer-beavatkozások

3
Iratkozz fel